Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
A highly purified, inactivated tick-borne encephalitis (TBE) virus particle vaccine has been developed. In this study we report on the efficacy of this new vaccine to protect against TBE virus isolates from different geographical areas of Europe and the Asian part of the USSR.
Klockmann
U
U
Behringwerke AG, Department of Microbiology Research, Marburg, Germany.
Krivanec
K
K
Stephenson
J R
JR
Hilfenhaus
J
J
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology*; D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D005260:Female; D008146:Louping Ill / Q000517:prevention & control; D051379:Mice; D009500:Neutralization Tests; D014611:Vaccination; D015164:Vaccines, Inactivated / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D015164:Vaccines, Inactivated; D014765:Viral Vaccines